Xiangxue PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 2/6
Xiangxue PharmaceuticalLtd has a total shareholder equity of CN¥2.1B and total debt of CN¥2.3B, which brings its debt-to-equity ratio to 108.6%. Its total assets and total liabilities are CN¥8.1B and CN¥5.9B respectively.
Key information
108.6%
Debt to equity ratio
CN¥2.30b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥75.60m |
| Equity | CN¥2.12b |
| Total liabilities | CN¥5.94b |
| Total assets | CN¥8.05b |
Recent financial health updates
No updates
Recent updates
Xiangxue Pharmaceutical Co.,Ltd. (SZSE:300147) Held Back By Insufficient Growth Even After Shares Climb 36%
Oct 15
Xiangxue Pharmaceutical Co.,Ltd.'s (SZSE:300147) Shares Bounce 25% But Its Business Still Trails The Industry
Jul 31Benign Growth For Xiangxue Pharmaceutical Co.,Ltd. (SZSE:300147) Underpins Stock's 29% Plummet
Jun 07Xiangxue Pharmaceutical Co.,Ltd.'s (SZSE:300147) Price Is Right But Growth Is Lacking After Shares Rocket 38%
Mar 12Financial Position Analysis
Short Term Liabilities: 300147's short term assets (CN¥1.9B) do not cover its short term liabilities (CN¥5.2B).
Long Term Liabilities: 300147's short term assets (CN¥1.9B) exceed its long term liabilities (CN¥780.9M).
Debt to Equity History and Analysis
Debt Level: 300147's net debt to equity ratio (105.1%) is considered high.
Reducing Debt: 300147's debt to equity ratio has increased from 75.5% to 108.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 300147 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 300147 has less than a year of cash runway if free cash flow continues to grow at historical rates of 43.9% each year.